Doctor profile · Federal record

Dr. Rama Koya, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Medical Oncology Physician · Longview, TX

  • NPI 1407895832
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 41 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1300 N 4Th St
Longview, TX 756014717
(903) 757-2122
fax (903) 757-9475
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
September 8, 2025
Year of graduation
1985 — 41 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Texas #L1097
Medicaid (3)
TX #40593801 · TX #40593805 · TX #40593804

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1407895832. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
57,823
Distinct HCPCS
10
Medicare allowed
$1,004,324
HCPCS Description Services Patients Avg allowed
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 13,581 105 $0
J1756 Injection, iron sucrose, 1 mg 11,000 27 $0
J9271 Injection, pembrolizumab, 1 mg 10,400 18 $54
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 9,180 15 $0
36415 Insertion of needle into vein for collection of blood sample 2,339 451 $8
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,889 433 $8
80053 Blood test, comprehensive group of blood chemicals 1,625 446 $10
J1100 Injection, dexamethasone sodium phosphate, 1 mg 728 36 $0
99214 Established patient office or other outpatient visit, 30-39 minutes 601 246 $122
99213 Established patient office or other outpatient visit, 20-29 minutes 442 287 $86

In context: peer comparison

Among 2 peers in this city , average services per provider: 857. This provider delivers 67× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$1,844
Transactions
40
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals LP 7 $1,025.16
ABBVIE INC. 4 $155.85
E.R. Squibb & Sons, L.L.C. 6 $96.52
Daiichi Sankyo Inc. 3 $85.60
Janssen Biotech, Inc. 2 $79.74
Aveo Pharmaceuticals, Inc. 2 $65.16
GlaxoSmithKline, LLC. 3 $59.42
Incyte Corporation 2 $52.87
Lilly USA, LLC 3 $52.49
Merck Sharp & Dohme LLC 2 $49.30
SOBI, INC 2 $45.66
Mirati Therapeutics, Inc. 1 $23.79
Bayer Healthcare Pharmaceuticals Inc. 1 $19.53
GENZYME CORPORATION 1 $18.38
PUMA BIOTECHNOLOGY, INC. 1 $14.38

By nature of payment

Consulting Fee
$910
Food and Beverage
$839
Education
$95

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,267
Patients
351
Total drug cost
$116,988
Drug Type Claims Patients Total cost
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 179 30 $4,145
Potassium Chloride Generic 165 49 $4,796
Exemestane Generic 154 32 $30,420
Anastrozole Generic 85 26 $1,960
Levothyroxine Sodium Generic 85 21 $972
Eliquis (Apixaban) Brand 82 18 $59,651
Prednisone Generic 76 21 $634
Ondansetron Hcl Generic 65 35 $808
Hydroxyurea Generic 61 15 $2,009
Allopurinol Generic 57 13 $644

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Rama Koya's medical specialty?
Dr. Rama Koya practices Hematology & Oncology Physician in Longview, TX.
Where does Dr. Rama Koya practice?
Dr. Rama Koya practices at 1300 N 4Th St, Longview, TX 756014717. Office phone: 9037572122.
What is Dr. Rama Koya's NPI?
Dr. Rama Koya's National Provider Identifier (NPI) is 1407895832, issued by NPPES.
Does Dr. Rama Koya accept Medicare assignment?
Yes. Dr. Rama Koya accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Rama Koya commonly perform?
Top Medicare-reported procedures in 2023: Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS Q9967); Injection, iron sucrose, 1 mg (HCPCS J1756); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.